Literature DB >> 28029310

Reply to H.J.A. Adams et al and E. Laffon et al.

Michel Meignan1, Anne Ségolène Cottereau1, Annibale Versari1, Loïc Chartier1, Jehan Dupuis1, Sami Boussetta1, Ilaria Grassi1, René-Olivier Casasnovas1, Corinne Haioun1, Hervé Tilly1, Vittoria Tarantino1, Julien Dubreuil1, Massimo Federico1, Gilles Salles1, Stefano Luminari1, Judith Trotman1.   

Abstract

Year:  2016        PMID: 28029310     DOI: 10.1200/JCO.2016.71.0459

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Optimal method for measuring baseline metabolic tumor volume in DLBCL patients: are statistical agreements of SUV ≥2.5 satisfactory?

Authors:  Eric Laffon; Roger Marthan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-17       Impact factor: 9.236

2.  Reply to E. Laffon et al.

Authors:  Clément Bailly; Thomas Carlier; Françoise Kraeber-Bodéré; Steven Le Gouill; Caroline Bodet-Milin
Journal:  Haematologica       Date:  2020-01       Impact factor: 9.941

3.  Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy.

Authors:  Murali Kesavan; Jan Boucek; William MacDonald; Andrew McQuillan; J Harvey Turner
Journal:  Diagnostics (Basel)       Date:  2017-05-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.